Clinical Trial Update: Ofatumumab Added to Fludarabine-Cyclophosphamide vs Fludarabine-Cyclophosphamide Combination in Relapsed Subjects With Chronic Lymphocytic Leukemia [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating ofatumumab added to fludarabine-cyclophosphamide versus fludarabine-cyclophosphamide in relapsed chronic lymphocytic leukemia; results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Fludarabine/Cyclophosphamide
• Ofatumumab (ofatumumab)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Leukaemia, Lymphocytic, Chronic | Phase 3 | Status: COMPLETED | Results posted: 2016-07-25